Indian students in Germany need not pay to study: Envoy

October 22, 2012

india_students_in_germany


New Delhi, October 22: Germany, a hub of quality scientific research and innovation, is keen to attract the brightest Indian minds for further studies and research and has as an incentive made it easier for students to stay over and work, the country's envoy has said. Another incentive for students is that German universities don't charge any fees.

"In Germany you don't pay to study in the universities," Michael Steiner, Germany's envoy to India, told IANS in an interview.

The students only have to pay for their board and lodging, he added.
There are at present 6,000 Indian students in Germany, and the country is eager to attract more, he said.


"Earlier, students who wanted to stay over could not, and this was a problem. This year, we have facilitated that students keen to stay over and work can do so," Mr Steiner said. This would be done on the basis of specific work permits.

And, to give a fillip to Indo-German scientific and technological cooperation, Germany is setting up an institute in Delhi to facilitate the exchange of science and innovation, Mr Steiner said, describing it as "one of the defining pillars of our bilateral relations".

The German House for Research and Innovation (DWIH), New Delhi, coming up on Oct 27 near the German embassy here, will help Indian students wanting to go to Germany and vice versa, as well as facilitate bilateral research projects, he said.


The DWIH "will be part of the Ivy League from our perspective", he said.

The ambassador does not foresee language to be a barrier for Indian students as German universities now offer courses in English, he said.

"But it is an enrichment to learn the German language... And it has been observed that Indians are good at learning German," Mr Steiner said.

The DWIH will act like a hub for young talents and a house for scientific innovation, which is one of Germany's strengths, said the ambassador.

Among the 14 universities and member institutions of the DWIH are the well-known Heidelberg University, the Max Planck Society and the University of Cologne.

"The DWIH is mainly an address for facilitating study in Germany," he said, adding that there was an increase of 20 percent in the number of Indian students going to Germany in 2011 from the previous year.

"This is encouraging, but we expect a further increase," he said.

The DWIH is one of the five set up by Germany across the world, with the others in Sao Paolo (Brazil), Moscow (Russia), New York (USA) and Tokyo (Japan)

To a question on how much a student would have to spend to stay in Germany, Mr Steiner said it depends on the city.

"We have very good universities in small cities. It all depends on where the student wants to go," he said, adding that staying in Berlin would be relatively cheaper than Munich.

According to a study by the Indian Institute of Management-Bangalore, more than 53,000 Indians went abroad in 2000 for a degree and at the end of the decade, the count shot up to 190,000.

The US is the top country having most number of Indian students, with the UK a close second. Between 2000 and 2009, the number of Indian students in Europe increased from 3,348 to 51,556, with the UK seeing a rise from 3,962 to 36,105.

Mr Steiner was full of praise for India's excellence in the field of IT and German companies' collaboration with Indian firms.

"I have spoken to Infosys Germany and found them pretty impressive," he said.

Infosys is in collaboration with German IT major SAP, while Wipro has tied up with Siemens.



Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Washington, Apr 24: President Donald Trump has favoured a phased reopening of the US economy, devastated by the coronavirus pandemic, which has claimed nearly 50,000 lives and infected over eight lakh people in the country.

More than 95 per cent of the country's 330 million people are under stay-at-home order as a result of the social mitigation measures, including social distancing, being enforced till May 1.

Trump on Thursday indicated that the stay-at-home order might be extended beyond May 1, but vehemently advocated the need to gradually open up the economy.

In the past few weeks, more than 26 million Americans have filed for unemployment benefits and the figure is soon likely to cross 40 million.

Both the World Bank and the International Monetary Fund (IMF) have projected a negative growth in the US in 2020.

To keep America gaining momentum, every citizen needs to maintain the vigilance, and we all understand that very well we've gone over it many, many times this includes practising good hygiene, maintaining social distance, and the voluntary use of face covering, Trump said.

Safe and phased reopening of our economy -- it's very exciting, but it does not mean that we are letting down our guard at all in any way; on the contrary, continued diligence is an essential part of our strategy to get our country back to work to take our country back, he told reporters at his daily White House news conference on coronavirus.

The data and facts on the ground suggest that the US is making great progress, he said.

In 23 states, new cases have declined. In the peak week, 40 per cent of the American counties have seen a rapid decline in new cases. As many as 46 states report a drop in patients showing coronavirus-like symptoms, he said.

Trump said the US is very close to finding a vaccine for COVID-19.

We are very close to testing... when testing starts it takes a period of time but we will get it done, he said.

According to Vice President Mike Pence, data continues to show promising signs of progress in the New York Metro area, New Jersey, Connecticut, Detroit and New Orleans. All appear to be passed their peak and we are seeing consistent declines in hospitalisation and cases in regions across the country, he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 10,2020

Tehran, Mar 10: Twenty-seven people have died from methanol poisoning in Iran after rumours that drinking alcohol can help cure the novel coronavirus infection, state news agency IRNA reported on Monday. The outbreak of the virus in Islamic republic is one of the deadliest outside of China, where the disease originated.

Twenty have died in the southwestern province of Khuzestan and seven in the northern region of Alborz after consuming bootleg alcohol, IRNA said.

Drinking alcohol is banned in Iran for everyone except some non-Muslim religious minorities. Local media regularly report on lethal cases of poisoning caused by bootleg liquor.

A spokesman for Jundishapur medical university in Ahvaz, the capital of Khuzestan, said 218 people had been hospitalised there after being poisoned.

The poisonings were caused by "rumours that drinking alcohol can be effective in treating coronavirus," Ali Ehsanpour said.

The deputy prosecutor of Alborz, Mohammad Aghayari, told IRNA the dead had drunk methanol after being "misled by content online, thinking they were fighting coronavirus and curing it." If ingested in large quantities, methanol can cause blindness, liver damage and death.

Iran has been scrambling to contain the spread of the COVID-19 illness which has hit all of the country's 31 provinces, killing 237 people and infecting 7,161.

According to IRNA, 16 out of 69 confirmed cases have died of coronavirus infection in Khuzestan as of Sunday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.